Performance Plus Marketing Recalls Libigrow, Libigrow XXXtreme, Blue Diamond, Blue Diamond Platinum, Mojo Nights, Mojo Nights Supreme, Casanova Supplements

Performance Plus Marketing, Inc. is recalling Libigrow®, Libigrow XXXtreme®, Blue Diamond®, Blue Diamond Platinum®, Mojo Nights®, Mojo Nights Supreme®, and Casanova® because they contain undeclared Sulfoaildenafil and Thioaildenafil.

Performance Plus Marketing, Inc. has been informed by the US Food and Drug Administration (FDA) that FDA lab analysis of Mojo Nights® distributed by the company was found to contain undeclared sulfoaildenafil and thioaidenafil, which are analogues of sildenafil. Counterfeit of Libigrow® brands have also test positive for sildenafil and other analogues thereof. Sildenafil is an FDA-approved drug for the treatment of male Erectile Dysfunction (ED), making Libigrow®, Libigrow XXXtreme®, Blue Diamond®, Blue Diamond Platinum®, Mojo Nights®, Mojo Nights Supreme®, and Casanova® unapproved drugs.

Sulfoaildenafil and thioaildenafil are close in structure to sildenafil and are expected to possess a similar pharmacological and adverse event profile. This poses a threat to consumers because sildenafil may interact with nitrates found in some prescription drugs such as nitroglycerin and may lower blood pressure to dangerous levels. Consumers with diabetes, high blood pressure, high cholesterol, or heart disease often take nitrates.

Recall includes ALL authentic Lot numbers and *known to be counterfeit lot numbers of authentic lots. Any packaging types that are different from listed are counterfeit. Any lot numbers not listed are counterfeit and are also part of the recall.

Product UPC Code Packaging Type Number of Capsules Lot Numbers Expiration Date
Libigrow® 094922567611 1-count blister 1 *791115 12/13
*01M0111 01/14
*01M0212-1 02/15
*01M0212 02/15
*01M0611-2 06/14
094922567628 5-count blister 5 05M0412 04/16
610585434253 10-count blister 10 10M0412 04/16
Libirgow XXX® 705105830735 1-count blister 1 *01MNU0912 09/15
*01X0412-1 04/15
*021647 12/13
610585435939 5-count blister 5 05X0412 04/16
610585435922 10-count blister 10 10X0412 04/16
10-count blister 10 10M0111 01/14
Blue Diamond® 705105524764 1-count blister 1 *01M0412 04/15
1 *91782 01/14
736211124012 5-count blister 5 05M0412 04/15
736211123916 10-count blister 10 10M0412 04/15
Blue Diamond Platinum® 608641933543 1-count blister 1 01MNU0912 08/15
608641932867 5-count blister 5 05BD0712 07/15
121781 01/14
608641933536 10-count blister 10 05BD0712 07/15
Mojo Nights® 718122119738 1-count blister 1 *01MJ0712 07/15
718122119738 1-count blister 1 *01MM0211 07/15
705105836430 5-count blister 5 05M0912 10/15
Mojo Nights Supreme® 610585435915 1-count blister 1 01MJS0712 07/15
Casanova® 736211906892 1-count blister 1 *030112 03/15

Libigrow®, Libigrow XXXtreme®, Blue Diamond®, Blue Diamond Platinum®, Mojo Nights®, Mojo Nights Supreme®, and Casanova® are marketed as a dietary supplement sexual enhancer for men. The product was sold to distributors and retail stores nationwide and via internet sales.

No illnesses or injuries have been reported to the company to date in connection with this product.

Performance Plus Marketing, Inc., a California Corporation, is committed to providing accurate information about its products because of concerns for the health and safety of consumers. Performance Plus Marketing, Inc. is working voluntarily with the FDA in the recall process. It sincerely regrets any inconvenience to customers. The company has discontinued distribution of these affected products until further notice.

Consumers should not consume Libigrow®, Libigrow XXXtreme®, Blue Diamond®, Blue Diamond Platinum®, Mojo Nights®, Mojo Nights Supreme®, and Cassanova® should return it immediately to the place of purchase for a full refund. Consumers should contact their physician if they have experienced any problems that may be related to taking these products. Consumers with questions should contact the recall coordinator at 800-625-8806, Monday through Friday, 9:00 am to 5:30 pm, PST.

Consumers and health care professionals should report adverse events that may be related to the use of this product to the U.S. Food and Drug Administration’s (FDA) MedWatch Adverse Events Program either online, by regular mail or by fax.

This recall is being conducted with the knowledge of the U.S. Food and Drug Administration.

About

Many of our food, drug and medical device recall alerts come from press releases distributed by the United States Food and Drug Administration (FDA) for public use and redistribution by news outlets likes US Recall News.

Leave a Reply

Please type the characters of this captcha image in the input box

Please type the characters of this captcha image in the input box